Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.
Church TR, Wandell M, Lofton-Day C, Mongin SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T, Osborn N, Snover D, Day RW, Ransohoff DF; PRESEPT Clinical Study Steering Committee, Investigators and Study Team. Church TR, et al. Among authors: blumenstein ba. Gut. 2014 Feb;63(2):317-25. doi: 10.1136/gutjnl-2012-304149. Epub 2013 Feb 13. Gut. 2014. PMID: 23408352 Free PMC article.
Controversies in the treatment of metastatic prostate cancer.
McLeod DG, Crawford ED, Blumenstein BA, Eisenberger MA, Dorr FA. McLeod DG, et al. Among authors: blumenstein ba. Cancer. 1992 Jul 1;70(1 Suppl):324-8. doi: 10.1002/1097-0142(19920701)70:1+<324::aid-cncr2820701321>3.0.co;2-g. Cancer. 1992. PMID: 1600494 Clinical Trial.
Leuprolide with and without flutamide in advanced prostate cancer.
Crawford ED, Blumenstein BA, Goodman PJ, Davis MA, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA. Crawford ED, et al. Among authors: blumenstein ba. Cancer. 1990 Sep 1;66(5 Suppl):1039-44. doi: 10.1002/cncr.1990.66.s5.1039. Cancer. 1990. PMID: 2118417 Clinical Trial.
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer.
Bellmunt J, Eigl BJ, Senkus E, Loriot Y, Twardowski P, Castellano D, Blais N, Sridhar SS, Sternberg CN, Retz M, Pal S, Blumenstein B, Jacobs C, Stewart PS, Petrylak DP. Bellmunt J, et al. Ann Oncol. 2017 Oct 1;28(10):2481-2488. doi: 10.1093/annonc/mdx400. Ann Oncol. 2017. PMID: 28961845 Free article. Clinical Trial.
Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.
Moinpour CM, Savage MJ, Troxel A, Lovato LC, Eisenberger M, Veith RW, Higgins B, Skeel R, Yee M, Blumenstein BA, Crawford ED, Meyskens FL Jr. Moinpour CM, et al. Among authors: blumenstein ba. J Natl Cancer Inst. 1998 Oct 21;90(20):1537-44. doi: 10.1093/jnci/90.20.1537. J Natl Cancer Inst. 1998. PMID: 9790546 Clinical Trial.
A clinical development paradigm for cancer vaccines and related biologics.
Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G; Cancer Vaccine Clinical Trial Working Group. Hoos A, et al. J Immunother. 2007 Jan;30(1):1-15. doi: 10.1097/01.cji.0000211341.88835.ae. J Immunother. 2007. PMID: 17198079 Free article. Review.
Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer.
Taplin ME, Antonarakis ES, Ferrante KJ, Horgan K, Blumenstein B, Saad F, Luo J, de Bono JS. Taplin ME, et al. Eur Urol. 2019 Dec;76(6):843-851. doi: 10.1016/j.eururo.2019.08.034. Epub 2019 Sep 18. Eur Urol. 2019. PMID: 31542304 Clinical Trial.
103 results